Session » Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma
-
Abstract Number: 1724
Disease Manifestations and Impact on Quality of Life in Subjects with Pre-Pubertal Onset Systemic Lupus Erythematosus
-
Abstract Number: 1725
Disease Activity in Childhood-Onset Systemic Lupus Erythematosus: Initial Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
-
Abstract Number: 1726
Disease Activity and Health Care Utilization Among Young Adults with Childhood-onset Lupus Transitioning to Adult Care: Follow-Up Data from the Pediatric Lupus Outcomes Study
-
Abstract Number: 1727
Worsening Disease Activity and Inability to Taper Corticosteroids in an Ethnically Diverse Cohort of Pediatric-Onset Lupus Patients After Transition to Adult Care
-
Abstract Number: 1728
Persistent Disease Activity Is Associated with Avascular Necrosis Development in Juvenile Systemic Lupus Erythematosus
-
Abstract Number: 1729
Infections and Mortality in 230 Childhood Lupus Patients: A Single Center Experience from North India
-
Abstract Number: 1730
Impact of Preceding and Co-existing Autoimmune Cytopenias on Severity of Childhood-onset Systemic Lupus Erythematosus: A Single-Center Retrospective Cohort Study
-
Abstract Number: 1731
Validation of the 2017 Weighted Criteria in Pediatric Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1732
Evaluating the New 2018 ACR/EULAR SLE Classification in Pediatric Patients
-
Abstract Number: 1733
Long-term Renal Survival of Pediatric Onset Lupus Patients in a Population-Based Cohort
-
Abstract Number: 1734
Low Bone Mineral Density Was Associated with Lupus Nephritis Irrespective of Duration on Steroid Treatment in a Large Observational Study of Juvenile Systemic Lupus Erythematosus Patients
-
Abstract Number: 1735
Clinical Variables Influencing Prednisone Dosing Towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
-
Abstract Number: 1736
Cognitive Impairment in Childhood-Onset Systemic Lupus Erythematosus: Early Detection with MRI Spectroscopy and Its Association with MOG Antibodies
-
Abstract Number: 1737
Systemic Vascular Involvement in Kawasaki Disease: A Single Center Cohort
-
Abstract Number: 1738
Tracking Whole-Brain Volumetric Trends in Childhood-onset Systemic Lupus Erythematosus Patients in the Clinical Setting by Magnetic Resonance Imaging
-
Abstract Number: 1739
Kawasaki Disease Shock Syndrome – More Common Than We Think: Our Experience at Chandigarh, North India
-
Abstract Number: 1740
Orange Brown Chromonychia in Kawasaki Disease: A Clinical Sign That Merits Greater Attention
-
Abstract Number: 1741
Depression and Anxiety Symptoms in Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 1742
Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort
-
Abstract Number: 1744
Serum Sickness Following Rituximab Treatment of Childhood-Onset SLE: A Single Center Experience
-
Abstract Number: 1745
Exercise Improves Arterial Inflammation in Childhood-onset Takayasu Arteritis: A Randomized Controlled Trial
-
Abstract Number: 1746
Identifying Additional Risk Factors for Arterial and Venous Thrombosis Among Pediatric Antiphospholipid Antibodies Carriers
-
Abstract Number: 1747
Practice Variations in Treatment of Pediatric Anti-neutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (AAV) with Renal Disease
-
Abstract Number: 1748
Incidence of Retinopathy in Individuals Who Initiated Hydroxychloroquine Therapy During Childhood
-
Abstract Number: 1749
Improving Eye Screening Among Pediatric Rheumatology Patients Receiving Hydroxychloroquine: Experience of a Quaternary Care Center
-
Abstract Number: 1750
Pediatric Sjögren Syndrome: A Single-Center Experience
-
Abstract Number: 1751
A Systematic Literature Review of Efficacy and Safety of Biologic Agents for the Treatment of Juvenile Dermatomyositis
-
Abstract Number: 1752
Is Early Standardized Rituximab Therapy Sufficient for Toddlers with NMDAR Encephalitis?
-
Abstract Number: 1753
Are Patterns of Early Disease Severity Predictive of Grade 12 Academic Achievement in Patients with Childhood-onset Chronic Rheumatic Diseases?
-
Abstract Number: 1754
Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
-
Abstract Number: 1755
Improving Adolescent Health Care Transition: Piloting the Transition Readiness Assessment Questionnaire
-
Abstract Number: 1756
Health-related Social Media Use by Parents of Children with Rheumatic Diseases